Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Here you go: The New England Journal of Medicin

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155379
(Total Views: 859)
Posted On: 04/07/2020 8:24:23 PM
Avatar
Posted By: ClosetInvestor
Re: HCIT #26208
Here you go:

The New England Journal of Medicine (NEJM) is the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, and the global medical community.

Our mission is to bring physicians the best research and information at the intersection of biomedical science and clinical practice and to present this information in understandable and clinically useful formats that inform health care delivery and improve patient outcomes.
To these ends, the NEJM editorial team employs rigorous:

Editorial, peer, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance.

Policies and practices to ensure that authors disclose all relevant financial associations and that such associations in no way influence the content NEJM publishes.

A truly global brand, NEJM keeps health care professionals at the leading edge of medical knowledge, helps them to gain broad understanding in their areas of interest, and provides valuable perspectives on the practice of medicine.

NEJM History
John Collins Warren, a Boston physician and scholar, collaborated in 1811 with colleague James Jackson to establish the first medical journal in New England, publishing the first quarterly edition of the New England Journal of Medicine and Surgery and the Collateral Branches of Medical Science (Boston) in January of 1812.

In 1921, the journal merged with the Boston Medical Intelligencer to become the Boston Medical and Surgical Journal; it also began weekly publication that year and was purchased by the Massachusetts Medical Society.
Renamed to the New England Journal of Medicine in 1928, the journal is known for many firsts in medicine, including the first to publish a full description of spinal disk rupture (1934), the first to document success in treating early childhood leukemia (1948), and the first American medical journal to receive the Polk Award for journalistic excellence. For additional NEJM historical milestones, see Fact Sheet.

NEJM Today
Today, NEJM is the most widely read, cited, and influential general medical periodical in the world. More than 600,000 people from nearly every country read NEJM in print and online each week.
Each year, NEJM receives more than 16,000 research and other submissions for consideration for publication. About 5% of original research submissions achieve publication by NEJM; more than half originate from outside the U.S.

NEJM is cited more often in scientific literature than any other medical journal, and has the highest Journal Impact Factor (70.670) of all general medical journals (2018 Journal Citation Reports, Web of Science Group, 2019).

NEJM is a Public Access Journal. All original research content is freely available on NEJM.org six months after the date of publication. In addition, qualifying low-income countries are granted free access to all articles on NEJM.org dating back to 1990. The editors may also make certain materials including articles on global health and of public health importance free to all readers immediately upon publication on NEJM.org


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us